✦ LIBER ✦

PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

✍ Scribed by A. Marcellusi; N. Bansback; S. Rao; M. Cifaldi; L. Gitto; P. Giannantoni; S. Russo; F.S. Mennini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS37 Economic Evaluation Model of Biolo

✍ X. Wang; N. Bansback; A. Anis; A.D. Joshi; S. Rao; M. Wolff; M. Cifaldi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PSS11 Economic Evaluation of Biologic Tr

✍ Marcellusi, A.; Gitto, L.; Giannantoni, P.; Attinà, G; Sundaram, M.; Mennini, F. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS46 Economic Evaluation of Adalimumab

✍ A. Benedict; T. Kongnakorn; J.W. Shaw; A. Marcellusi; D.J. Vanness; L. Gitto; P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS54 COST-EFFECTIVENESS OF TOCILIZUMAB

✍ Diamantopoulos, A; Wintfeld, N; Giuliani, G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-effectiveness modeling of abatacept

✍ Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 183 KB

PMS40 COST-EFFECTIVENESS SIMULATION MODE

✍ Beresniak, A; Baerwald, C; Zeidler, H; Gromnica-lhle, E; Kruger, K; Neubauer, AS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB